SCHEMBL1995018

SCHEMBL1995018

C[C@H](Oc1ccc(F)cc1-c1ccc(S(=O)(=O)c2ccccc2)cc1Cl)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 10/20 0.48
RORC P51449 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
APP P05067 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ABCC9 O60706 1/20 0.34
ABCC8 Q09428 1/20 0.34
KCNJ11 Q14654 1/20 0.34
KCNJ8 Q15842 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
KCNH2 Q12809 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989949 0.88 PTGDR2 (0.57) PTGDR2RORCMEN1KMT2AHTR2A
SCHEMBL1995019 0.82 PTGDR2 (0.46) PTGDR2RORCMEN1KMT2AABCC9
SCHEMBL1988973 0.79 PTGDR2 (0.41) PTGDR2APPHTR2AHTR2C
SCHEMBL1995021 0.79 PTGDR2 (0.41) PTGDR2RORCMEN1KMT2AABCC9
SCHEMBL1989639 0.78 MEN1 (0.46) PTGDR2MEN1KMT2AHTR2AHTR2C
SCHEMBL1690289 0.77 PTGDR2 (0.60) PTGDR2TDP1HTR2AHTR2CLMNA
SCHEMBL1989827 0.74 PTGDR2 (0.44) PTGDR2ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL1990136 0.73 PTGDR2 (0.52) PTGDR2KMT2AABCC9ABCC8KCNJ11
SCHEMBL1995373 0.72 HTR2A (0.45) PTGDR2MEN1KMT2AHTR2AHTR2C
SCHEMBL14432862 0.72 CNR1 (0.40) PTGDR2ALOX5APFEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PTGDR2 568/4885RORC 102/4885MEN1 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.